Brookline downgraded Syros Pharmaceuticals (SYRS) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback